Skip to main content
HLB Life Science CO.,LTD. logo

HLB Life Science CO.,LTD. — Investor Relations & Filings

Ticker · 067630 ISIN · KR7067630004 LEI · 9884006PTFB20S9PS149 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2024-12-16 Capital/Financing Update
Country KR South Korea
Listing KO 067630

About HLB Life Science CO.,LTD.

https://www.hlb-lsmc.com/

HLB Life Science is a specialized pharmaceutical and biotechnology firm focused on the development of innovative anti-cancer medications and the manufacturing of medical devices. The company's research and development efforts center on targeted therapies and cell therapies for oncology. In parallel, it develops, manufactures, and distributes in vitro diagnostic (IVD) medical devices and quasi-drugs. The company's portfolio also includes the clinical development of anti-cancer drugs for animals, aiming to provide comprehensive solutions across human and animal health.

Recent filings

Filing Released Lang Actions
신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from HLB Life Science regarding the acquisition of its own bonds (specifically Bond with Warrant, BW) before maturity. This type of corporate action, involving the repurchase or redemption of debt instruments, falls under capital structure changes and financing updates. In the context of the provided categories, 'CAP' (Capital/Financing Update) is the most accurate classification for announcements regarding the redemption or acquisition of issued debt securities.
2024-12-16 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming 27th Annual General Meeting. It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of the record date. Given its nature as a regulatory notification regarding corporate governance procedures, it fits best under the RNS category.
2024-12-16 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification of the exercise of conversion rights (전환청구권행사) for convertible bonds into shares. This type of filing relates to changes in the company's capital structure, specifically the issuance of new shares resulting from the conversion of debt instruments. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the appropriate category for announcements regarding new share issues or capital changes.
2024-12-10 Korean
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from HLB Life Science regarding the adjustment of the conversion price of convertible bonds (Refixing). This type of disclosure relates to changes in the company's capital structure and financial instruments. Since it specifically details the adjustment of conversion prices and the resulting change in the number of convertible shares, it falls under the category of capital and financing updates.
2024-11-29 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for HLB Life Science Co., Ltd. for the period ending September 30, 2024. It contains detailed financial information, business descriptions, management discussions, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This type of filing is specifically used to report insider transactions or changes in share ownership by company directors and executives. According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2024-11-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.